Naveen Rathor

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Helen M. Colhoun, Ildiko Lingvay, Paul Brown et al. · Nature Medicine · 2024 · 197 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT

Ildiko Lingvay, John Deanfield, Steven E. Kahn et al. · Diabetes Care · 2024 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the <scp>STEP</scp> 1–4 trials

Domenica Rubino, Naveen Rathor, Arya M. Sharma et al. · Diabetes Obesity and Metabolism · 2024 · 39 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Weight change and risk of obesity‐related complications: A retrospective population‐based cohort study of a <scp>UK</scp> primary care database

Kamlesh Khunti, Volker Schnecke, Christiane Lundegaard Haase et al. · Diabetes Obesity and Metabolism · 2023 · 32 citations · Full text

Public Health, Chronic Disease Prevention, Obesity Prevention +11

Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial

M Gabe, Astrid Breitschaft, Filip K. Knop et al. · Diabetes Obesity and Metabolism · 2024 · 32 citations · Full text

Agriculture, Nutritional Sciences, Pharmacology +17